Oh man, you must really like this stock if you're typically into Biotech. No phase 1, phase 2, phase 3 for us on this one, unless we're taking about phases in terms of licensing, grow, etc.. Either way, I see a lot less risk in this than waiting out the spikes on phases and final FDA approval for Pharma, but that's because you really need to understand the bio behind the drugs to dabble in companies going through trials.

I went long IBB over a year ago and I'm loving where it's at, even with the recent downward spike. This sub-sector might be the most lucrative investment opportunities in Biotech.